Empresa Reata Pharmaceuticals, Inc.
Acciones
RETA
US75615P1030
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 322
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director of Finance/CFO | 60 | 26/09/23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Mike Visnick
PRN | Corporate Officer/Principal | - | 01/01/07 |
Robin Kral
PRN | Corporate Officer/Principal | - | 01/01/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director/Board Member | - | 26/09/23 | |
Michael Dambach
BRD | Director/Board Member | - | 26/09/23 |
Robin Kramer
BRD | Director/Board Member | - | 26/09/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 3 | 4 515 246 | 0 | 0 | 75,54 % |
Acción B | 1 | 33 331 586 | 28 588 243 ( 85,77 %) | 0 |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |